#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Proteus syndrome Univentricular heart Gastric cancer Autoimmune myositis Philadelphia positive acute lymphocytic leukaemia Gastrooesophageal cancer Microvillous inclusion disease Adult T-cell lymphoma/leukaemia refractory Enteritis Heavy menstrual bleeding Marginal zone lymphoma Non-Hodgkin's lymphoma unspecified histology indolent Myelodysplastic syndrome Fibrosarcoma Anaplastic thyroid cancer More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Diagnostics Leiomyosarcoma – Treatment Chondrosarcoma – Trials in Disease Andersen-Tawil syndrome – Basic Information Idiopathic inflammatory myopathy – Diagnostics Phenylketonuria – Treatment Aicardi-Goutieres syndrome Glomerulonephritis membranous – Treatment Amyotrophic lateral sclerosis – Basic Information Leiomyosarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cd7-Cart01 Sargramostim Mebendazole Dexchlorpheniramine Maleate Nintedanib Dl-Alpha-Tocopherol Florquinitau (18F) Fosinopril Sodium GSKVX000000030810 Ecoo15 Bms-986442 ANOC-001 VG801-1 Niflumic Acid Triamcinolone Acetonide Pentixafor Gallium Ga-68 DESMOPRESSIN ACETATE Odm-111 Obinutuzumab Burfiralimab More therapies…

    Learn about Your Condition

    Peritonitis Tendon disorder Deafness bilateral Torticollis Graves' disease Cutaneous calcification Retinal neovascularisation Large cell lung cancer Agitation postoperative Dementia Alzheimer's type Hernia repair Hypophosphatasia Undifferentiated sarcoma Marfan's syndrome Nervous system disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety and Effects of SPK-3006 for Adults with Late-Onset Pompe Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Vanglusagene Ensiparvovec
    Germany

  • Study of Brain Injury and Concussion Symptoms Using Tau Tracer [18F]RO6958948 in Patients with Traumatic Brain Injury and Hemorrhages

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    Sweden

  • Study of Intrapleural Photodynamic Therapy with Aminolevulinic Acid Hydrochloride and Nivolumab for Patients with Malignant Pleural Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    • Nivolumab
    France

  • Study on Oxytocin Treatment for Children with Autism and Intellectual Disability

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study of Botulinum Toxin and Saline Solution for Erectile Dysfunction in Patients Unresponsive to Standard Treatments

    Recruiting

    2 1 1
    Investigated Diseases:
    • Erectile dysfunction
    Investigated Drugs:
    • Sodium Chloride Solution 0.9%
    Spain

  • Study on the Use of Methyl Aminolevulinate and PAGETEX Device for Treating Vulvar Extra-Mammary Paget’s Disease in Women

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paget’s disease of the vulva
    Investigated Drugs:
    • Methyl Aminolevulinate
    France
Previous Page
1 … 376 377 378 379 380 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!